Literature DB >> 19018009

Detection of complement activation on antigen microarrays generates functional antibody profiles and helps characterization of disease-associated changes of the antibody repertoire.

Krisztián Papp1, Péter Végh, Kata Miklós, Julianna Németh, Klára Rásky, Ferenc Péterfy, Anna Erdei, József Prechl.   

Abstract

Humoral immune responses are traditionally characterized by determining the presence and quality of Abs specific for certain Ags. Arraying of large numbers of Ags allows the parallel measurement of Abs, generating patterns called Ab profiles. Functional characterization of these Abs could help draw an even more informative map of an immune response. To generate functional Ab profiles we simultaneously tested not only IgM, IgG, and IgA binding to, but also complement activation by, a panel of endogenous and exogenous Ags printed as microarrays, using normal and autoimmune human sera. We show that complement activation by a particular Ag in a given individual cannot be predicted by the measurement of Ag-specific Abs, despite a general correlation between the amount of Ag-bound Ab and the deposited C3 fragments. This is due to both differences in the isotypes that dominate in the recognition of an Ag and individual variations for a given isotype, resulting in altered complement activation potential. Thus, Ag-specific C3 deposition can be used as an additional parameter in immune response monitoring. This is exemplified by comparing the coordinates of Ags, used for the diagnosis of systemic lupus erythematosus, of normal and autoimmune serum samples in a two-dimensional space derived from C3 deposition and Ab binding. Since cleavage fragments of C3 mediate important immunological processes, we propose that measurement of their deposition on Ag microarrays, in addition to Ab profiling, can provide useful functional signature about the tested serum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018009     DOI: 10.4049/jimmunol.181.11.8162

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Preliminary comparison of different immune and production components in local and imported Saanen goats reared under a sub-tropical environment.

Authors:  Elie K Barbour; Houssam H Itani; Fawwak T Sleiman; Maya F Saade; Steve Harakeh; Afif M Abdel Nour; Houssam A Shaib
Journal:  Trop Anim Health Prod       Date:  2011-07-01       Impact factor: 1.559

Review 2.  Why current quantitative serology is not quantitative and how systems immunology could provide solutions.

Authors:  József Prechl
Journal:  Biol Futur       Date:  2021-02-20

3.  Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy.

Authors:  Niall Brindl; Henning Boekhoff; Andrea S Bauer; Matthias M Gaida; Hien T Dang; Jörg Kaiser; Jörg D Hoheisel; Klaus Felix
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

4.  Application of fluorescent monocytes for probing immune complexes on antigen microarrays.

Authors:  Zoltán Szittner; Krisztián Papp; Noémi Sándor; Zsuzsa Bajtay; József Prechl
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

5.  Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium.

Authors:  József Prechl; Krisztián Papp; Zoltán Hérincs; Hajna Péterfy; Veronika Lóránd; Zoltán Szittner; Andone Estonba; Paolo Rovero; Ilaria Paolini; Jokin Del Amo; Maria Uribarri; Maria Claudia Alcaro; Otsanda Ruiz-Larrañaga; Paola Migliorini; László Czirják
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

6.  Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach.

Authors:  Sahar Ghassem-Zadeh; Katrin Hufnagel; Andrea Bauer; Jean-Louis Frossard; Masaru Yoshida; Hiromu Kutsumi; Hans Acha-Orbea; Matthias Neulinger-Muñoz; Johannes Vey; Christoph Eckert; Oliver Strobel; Jörg D Hoheisel; Klaus Felix
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.